WO2025074155 - PEPTIDE DRUG CONJUGATES AND THEIR USES

National phase entry:
Publication Number WO/2025/074155
Publication Date 10.04.2025
International Application No. PCT/IB2024/000551
International Filing Date 04.10.2024
Title **
[English] PEPTIDE DRUG CONJUGATES AND THEIR USES
[French] CONJUGUÉS PEPTIDES-MÉDICAMENTS ET LEURS UTILISATIONS
Applicants **
NATIONAL HEALTH RESEARCH INSTITUTES
Inventors
TSOU, Lun, Kelvin
LIU, Yu-Wei
CHEN, Chiung-Tong
CHIU, Tai-Yu
SHIH, Chuan
CHANG, Jang-Yang
Priority Data
63/542,861   06.10.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1990
EPO Filing, Examination, Granting13341
Japan Filing, Examination, Granting2234
South Korea Filing, Examination, Granting2246
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 24,551

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] are defined. Also provided are pharmaceutical compositions containing such a compound a method of treating cancer using the compound.[French] sont définis. L'invention concerne également des compositions pharmaceutiques contenant un tel composé, et un procédé de traitement du cancer à l'aide du composé.

Rejoining the server...